This week Robert Kemp grapples with two trials featured in Richard Lehman’s reviews in the BMJ, with a focus on surrogate outcomes.
In Richard’s Reviews this week, we look at progress in sharing clinical trial data through the All Trials campaign, and the nature of patient-centred outcomes research.
From Richard’s Reviews, Pishoy highlights the devastating effects of Ebola from a recent article in the New England Journal of Medicine “Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone” as well as give us a brief overview of the viral disease. Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone […]
This time we’re looking at a couple of pragmatically designed randomised controlled trials examining the role of integrated care programmes in treating COPD.
From Richard’s reviews, we look at a systematic review of management in poorly controlled type 2 diabetes and a study evaluating progress in reducing global childhood mortality.
From Richard’s Reviews, we highlight the importance of constantly rethinking how we manage patients with kidney stones (nephorlithiasis) and heart attacks (myocardial infarctions).
Sham devices can have a larger effect than placebo, should they remain to be under-regulated? Yamama tells us more.
From Richard’s review this week, we look at whether bisphosphonates can prevent breast cancer, and whether bivalirudin is actually any better than good old-fashioned heparin in patients with ACS undergoing percutaneous coronary intervention
From Richards’s Review this week, Pishoy highlights the resurrection of the BCG vaccine and the new gene on the block in the world of breast cancer.
Richard Lehman is a brilliant academic primary care physician who writes a weekly review of all the big journals; a number of our star bloggers (Pishoy, Nathan, Norah and Yamama) have taken the time to blog Richard’s Reviews for patients and students.
In this blog, Norah uses Richard Lehman’s review of journals for the BMJ to find and summarize the new and interesting publications in medical journals.
Nathan has picked out two parts of Richard’s Review for this week which he’s found especially interesting; Niacin, and Sjögren Syndrome.
This week RIchard talked about a hope he has had since long ago concerning a syndrome called Antiphospholipid Syndrome, Yamama tells us more.